Canada markets closed

Cresco Labs Inc. (CL.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
Add to watchlist
10.45-0.58 (-5.26%)
At close: 3:59PM EDT
Full screen
Previous Close11.03
Open10.84
Bid10.40 x 0
Ask10.58 x 0
Day's Range10.45 - 10.97
52 Week Range7.20 - 22.20
Volume240,224
Avg. Volume255,224
Market Cap2.796B
Beta (5Y Monthly)2.06
PE Ratio (TTM)N/A
EPS (TTM)-0.29
Earnings DateNov. 16, 2021 - Nov. 22, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Market Exclusive

    Cannabis Sector Weekly Roundup

    BioHarvest Sciences Inc., Icanic Brands Co Inc. & Cann Group Ltd. Among Top Cannabis Gainers For The Week. TerrAscend Corp & Columbia Care Inc Made the Headlines with Positive News. Key Developments to Note in the Proceedings of the Federal Legalization of Marijuana With State cannabis legalization ramping up across the U.S. and chances of […] The post Cannabis Sector Weekly Roundup appeared first on Market Exclusive.

  • Business Wire

    Cresco Labs Closes Acquisition of Cultivate, Strengthens Position in Massachusetts

    CHICAGO, September 03, 2021--CRESCO LABS CLOSES ACQUISITION OF CULTIVATE, STRENGTHENS POSITION IN MASSACHUSETTS

  • GlobeNewswire

    BriaCell Therapeutics Appoints Marc Lustig to its Board of Directors

    BERKELEY, Calif. and VANCOUVER, British Columbia, Sept. 01, 2021 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX-V: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company specializing in targeted immunotherapies for advanced breast cancer, announces the appointment of Mr. Marc Lustig to the Company's Board of Directors, effective September 1, 2021. Marc, through his investment company L5 Capital Inc., owns 1,530,000 common shares of BriaCell, repres